Prelude Therapeutics Inc (PRLD)

NASDAQ
39.15
-5.15(-11.63%)
After Hours
39.15
0.00(0.00%)
- Real-time Data
  • Volume:
    336,228
  • Bid/Ask:
    30.00/45.46
  • Day's Range:
    38.02 - 44.94

PRLD Overview

Prev. Close
44.3
Day's Range
38.02 - 44.94
Revenue
-
Open
44.65
52 wk Range
23.69 - 95.38
EPS
-10.6
Volume
336,228
Market Cap
1.84B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
210,861
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
46,958,198
Next Earnings Date
Jun 02, 2021
What is your sentiment on Prelude Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Prelude Therapeutics Inc News

Prelude Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsNeutralStrong SellStrong SellBuyBuy
SummarySellStrong SellStrong SellNeutralBuy

Prelude Therapeutics Inc Company Profile

Prelude Therapeutics Inc Company Profile

Employees
68

Prelude Therapeutics Inc. is a clinical-stage precision oncology company. The Company is focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers. Its drug discovery engine is designed to identify biological targets and create new chemical entities (NCEs). Its pipeline includes six programs including methyltransferases, kinases, protein-protein interactions and targeted protein degraders. It is developing therapies in both solid tumors and hematological malignancies such as adenoid cystic carcinoma (ACC), homologous recombination deficient positive (HRD+), cancers, myelofibrosis (MF) and glioblastoma multiforme (GBM), amongst others. The Company’s product candidates include PRT543, PRT811, PRT1419, SMARCA2, PRT2527 and PRT-K4.

Read More
  • Any thoughts on this???
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.